Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trial

BackgroundObesity is a socioeconomic problem, and visceral obesity, in particular, is related to cardiovascular diseases or metabolic syndrome. Fermented grains and various microorganisms are known to help with anti-obesity effects and weight management. Studies on the relationship between Bacillus...

Full description

Bibliographic Details
Main Authors: Eunbyul Cho, Ju Young Kim, Belong Cho, Joong Su Lee, Yeo Cho Yoon, Yong Chul Shin, Hyerim Kim, Siye Gil, Sohye Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1148512/full
_version_ 1797845561058000896
author Eunbyul Cho
Ju Young Kim
Belong Cho
Joong Su Lee
Yeo Cho Yoon
Yong Chul Shin
Hyerim Kim
Siye Gil
Sohye Kim
author_facet Eunbyul Cho
Ju Young Kim
Belong Cho
Joong Su Lee
Yeo Cho Yoon
Yong Chul Shin
Hyerim Kim
Siye Gil
Sohye Kim
author_sort Eunbyul Cho
collection DOAJ
description BackgroundObesity is a socioeconomic problem, and visceral obesity, in particular, is related to cardiovascular diseases or metabolic syndrome. Fermented grains and various microorganisms are known to help with anti-obesity effects and weight management. Studies on the relationship between Bacillus coagulans and anti-obesity effects are not well known, and studies on the application of fermented grains and microorganisms to the human body are also insufficient.ObjectivesThis study aimed to evaluate the efficacy of Curezyme–LAC, an ingredient mixed with six-grain types fermented by B. coagulans, in reducing fat mass in adults with obesity.MethodsIn this randomized double-blinded placebo-controlled study, 100 participants [aged 40–65 years; body mass index (BMI) ≥ 25 to ≤ 33 kg/m2) were randomly allocated to two groups: 4 g/day Curezyme–LAC administered as a granulated powder or placebo (steamed grain powder mixture).ResultsAfter 12 weeks, visceral adipose tissue decreased significantly in the Curezyme–LAC group compared with that in the placebo group (mean ± standard error, SE of −9.3 cm2 ± 5.1) vs. (6.8 cm2 ± 3.4; p = 0.008). Compared to the placebo group, the Curezyme–LAC group also showed significant reductions in total fat mass (−0.43 ± 0.24 kg vs. 0.31 ± 0.19 kg, p = 0.011), body weight (−0.4 ± 0.3 kg vs. 0.3 ± 0.2 kg, p = 0.021), BMI (−0.14 ± 0.12 vs. 0.10 ± 0.07, p = 0.028), and waist circumference (−0.6 ± 0.2 cm vs. −0.1 ± 0.2 cm, p = 0.018) without a change in dietary intake and physical activity.ConclusionCurezyme–LAC supplementation for 12 weeks may benefit individuals with obesity by reducing visceral fat mass.
first_indexed 2024-04-09T17:41:01Z
format Article
id doaj.art-be44109068384c8bba28301a0f21cfe3
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-04-09T17:41:01Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-be44109068384c8bba28301a0f21cfe32023-04-17T05:51:38ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2023-04-011010.3389/fnut.2023.11485121148512Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trialEunbyul Cho0Ju Young Kim1Belong Cho2Joong Su Lee3Yeo Cho Yoon4Yong Chul Shin5Hyerim Kim6Siye Gil7Sohye Kim8Department of Family Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of KoreaDepartment of Family Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of KoreaDepartment of Family Medicine, Seoul National University College of Medicine, Seoul, Republic of KoreaAmicogen, Inc., Jinju-si, Republic of KoreaAmicogen, Inc., Jinju-si, Republic of KoreaAmicogen, Inc., Jinju-si, Republic of KoreaDepartment of Family Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of KoreaDepartment of Family Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of KoreaNutrition Care Services, Seoul National University Bundang Hospital, Seongnam-si, Republic of KoreaBackgroundObesity is a socioeconomic problem, and visceral obesity, in particular, is related to cardiovascular diseases or metabolic syndrome. Fermented grains and various microorganisms are known to help with anti-obesity effects and weight management. Studies on the relationship between Bacillus coagulans and anti-obesity effects are not well known, and studies on the application of fermented grains and microorganisms to the human body are also insufficient.ObjectivesThis study aimed to evaluate the efficacy of Curezyme–LAC, an ingredient mixed with six-grain types fermented by B. coagulans, in reducing fat mass in adults with obesity.MethodsIn this randomized double-blinded placebo-controlled study, 100 participants [aged 40–65 years; body mass index (BMI) ≥ 25 to ≤ 33 kg/m2) were randomly allocated to two groups: 4 g/day Curezyme–LAC administered as a granulated powder or placebo (steamed grain powder mixture).ResultsAfter 12 weeks, visceral adipose tissue decreased significantly in the Curezyme–LAC group compared with that in the placebo group (mean ± standard error, SE of −9.3 cm2 ± 5.1) vs. (6.8 cm2 ± 3.4; p = 0.008). Compared to the placebo group, the Curezyme–LAC group also showed significant reductions in total fat mass (−0.43 ± 0.24 kg vs. 0.31 ± 0.19 kg, p = 0.011), body weight (−0.4 ± 0.3 kg vs. 0.3 ± 0.2 kg, p = 0.021), BMI (−0.14 ± 0.12 vs. 0.10 ± 0.07, p = 0.028), and waist circumference (−0.6 ± 0.2 cm vs. −0.1 ± 0.2 cm, p = 0.018) without a change in dietary intake and physical activity.ConclusionCurezyme–LAC supplementation for 12 weeks may benefit individuals with obesity by reducing visceral fat mass.https://www.frontiersin.org/articles/10.3389/fnut.2023.1148512/fullvisceral fatanti-obesityfermented grainBacillus coagulansweight management
spellingShingle Eunbyul Cho
Ju Young Kim
Belong Cho
Joong Su Lee
Yeo Cho Yoon
Yong Chul Shin
Hyerim Kim
Siye Gil
Sohye Kim
Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trial
Frontiers in Nutrition
visceral fat
anti-obesity
fermented grain
Bacillus coagulans
weight management
title Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trial
title_full Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trial
title_fullStr Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trial
title_full_unstemmed Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trial
title_short Efficacy of fermented grain using Bacillus coagulans in reducing visceral fat among people with obesity: a randomized controlled trial
title_sort efficacy of fermented grain using bacillus coagulans in reducing visceral fat among people with obesity a randomized controlled trial
topic visceral fat
anti-obesity
fermented grain
Bacillus coagulans
weight management
url https://www.frontiersin.org/articles/10.3389/fnut.2023.1148512/full
work_keys_str_mv AT eunbyulcho efficacyoffermentedgrainusingbacilluscoagulansinreducingvisceralfatamongpeoplewithobesityarandomizedcontrolledtrial
AT juyoungkim efficacyoffermentedgrainusingbacilluscoagulansinreducingvisceralfatamongpeoplewithobesityarandomizedcontrolledtrial
AT belongcho efficacyoffermentedgrainusingbacilluscoagulansinreducingvisceralfatamongpeoplewithobesityarandomizedcontrolledtrial
AT joongsulee efficacyoffermentedgrainusingbacilluscoagulansinreducingvisceralfatamongpeoplewithobesityarandomizedcontrolledtrial
AT yeochoyoon efficacyoffermentedgrainusingbacilluscoagulansinreducingvisceralfatamongpeoplewithobesityarandomizedcontrolledtrial
AT yongchulshin efficacyoffermentedgrainusingbacilluscoagulansinreducingvisceralfatamongpeoplewithobesityarandomizedcontrolledtrial
AT hyerimkim efficacyoffermentedgrainusingbacilluscoagulansinreducingvisceralfatamongpeoplewithobesityarandomizedcontrolledtrial
AT siyegil efficacyoffermentedgrainusingbacilluscoagulansinreducingvisceralfatamongpeoplewithobesityarandomizedcontrolledtrial
AT sohyekim efficacyoffermentedgrainusingbacilluscoagulansinreducingvisceralfatamongpeoplewithobesityarandomizedcontrolledtrial